We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Clinical Trial for New Anti-obesity Drug Set to Launch

News   Jul 10, 2019 | Original story from The Alberta Diabetes Institute

 
Clinical Trial for New Anti-obesity Drug Set to Launch

Dr. Andrea Haqq (left) is leading the Canadian component of an international clinical trail to test an anti-obesity drug for patients with rare genetic disorders linked to obesity. Credit: University of Alberta

 
 
 

RELATED ARTICLES

First CRISPR Law: Selling “Gene-therapy Kits” Will Be Illegal in California Unless They Carry a Warning

News

Authored by Senator Ling Ling Chang (R-Diamond Bar), Senate Bill 180 is a new consumer protection law that requires sellers of gene therapy kits known as “DIY CRISPR Kits” to include a notice prior to the point of sale, as well as a label, stating that CRISPR kits are not intended for self-administration.

READ MORE

“Special” CRISPR Permits Gene-editing of Stem Cell Derived Neurons

News

A team of scientists have achieved another CRISPR first, one which may fundamentally alter the way scientists study brain diseases.

READ MORE

Ebola Patients Have a 90% Survival Rate After Injection With New Drugs

News

Two Ebola drugs have proven so effective in a clinical trial that researchers will make the treatments available to anyone infected with the virus in the Democratic Republic of the Congo, where Ebola has killed nearly 1,900 people over the past year.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE